Pharmacyclics – Leader in Targeted Hematology Oncology

Pharmacyclics LLC

Pharmacyclics LLC is an innovative American biopharmaceutical company founded in 1991 (a subsidiary of AbbVie since 2015). The manufacturer specializes in developing highly effective targeted therapies for various forms of cancer, particularly hematological malignancies. Through scientific breakthroughs and the implementation of small molecule therapies, the company has become a global leader in blood cancer treatment. Pharmacyclics products meet the highest FDA standards, providing patients with access to world-class medical care.